help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 26, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1069
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
91/12/4888    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Völkl, T. M.K.
Right arrow Articles by Dörr, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Völkl, T. M.K.
Right arrow Articles by Dörr, H. G.

Submitted on May 17, 2006
Accepted on September 18, 2006

ALTERED 24-HOUR BLOOD PRESSURE PROFILES IN CHILDREN AND ADOLESCENTS WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

Thomas M.K. Völkl, Diemud Simm, Jörg Dötsch, Wolfgang Rascher, and Helmuth G. Dörr*

Divisions of Pediatric Endocrinologyand Nephrology, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Germany

* To whom correspondence should be addressed. E-mail: hgdoerr{at}kinder.imed.uni-erlangen.de.

Children and adolescents with classical congenital adrenal hyperplasia have been shown to be at risk for obesity associated with higher insulin and leptin levels. Since these factors are also known to cause hypertension the aim of this study was to analyze 24-hour blood pressure profiles and their relation to different clinical and laboratory parameters.

Design: 55 subjects, aged between 5.3 and 19.0 yr were enrolled in a prospective, cross-sectional study. All patients had genetically proven 21-hydroxylase deficiency and underwent ambulatory 24-hour blood pressure monitoring during a period off school/work (Mobil-O-GraphTM, I.E.M., Solberg, Germany).

Results (median, range): The median body mass index of the cohort was significantly elevated (1.09 SDS, -2.45 to 3.77). Daytime and night-time systolic blood pressures were also significantly elevated (0.67 SDS, -1.5 to 4.1; 0.63 SDS, -0.91 to 3.3), while daytime diastolic blood pressure was significantly lowered (-0.81 SDS, -2.6 to 3.2) and normal during the night (0.11 SDS, -2.0 to 2.0). Overall, there was a normal nocturnal drop of systolic (12.8%, 2.1 to 22.8) but not of diastolic blood pressure (17.2%, 0.90 to 25.8). The different parameters of systolic and diastolic blood pressures were significantly correlated with body mass index and skinfold thickness (rs=0.271 to 0.486). There was no correlation with equivalent hydrocortisone and fludrocortisone dosage, and laboratory parameters except for serum leptin and insulin.

Conclusions: Our data show altered 24-hour blood pressure profiles with elevated systolic levels correlated with the degree of overweight and obesity, whereas normal-weight patients tended to diastolic hypotension.


Key words: congenital adrenal hyperplasia • CAH • 21-hydroxylase • hypertension • blood pressure • obesity • leptin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society